Atrial fibrillation and atrial tachycardias (AF/AT) have been reported as a common condition in patients with pulmonary hypertension (PH). As yet, limited data exists about the significance of the borderline post-capillary pressure component on the occurrence of AF / AT in patients with isolated pre-capillary PH. We retrospectively studied the prevalence of AF / AT in 333 patients (mean age 61 ± 15 years, 44% males) with pre-capillary idiopathic / familiar pulmonary arterial hypertension, and inoperable chronic thromboembolic pulmonary hypertension. The prevalence of AF / AT was analyzed in different categories of pulmonary artery wedge pressure (PAWP). In the study population overall, the mean PAWP was 10.5 ± 3 mmHg, median of 11 mmHg, range 2-15 mmHg. AF / AT was diagnosed in 79 patients (24%). The proportion of AF / AT among patients with PAWP below the median (?11 mmHg) was lower than in subjects with PAWP between 12 and 15 mmHg, 30 (16%) vs. 46 (35%), p = 0.0001. Compared to the patients with PAWP?11 mmHg, subjects with PAWP between 12 and 15 mmHg were older (65 ± 13 years vs. 58 ± 16), with more prevalent arterial hyperte\nsion [100 (70%) vs. 106 (55%)] and diabetes mellitus [50 (35%) vs. 48 (25%)], showed larger size of the left atrium (42 ± 7 vs. 40 ± 6 mm), and higher values of right atrium pressure (12 ± 5 vs. 8 ± 5 mm Hg), p < 0.05 in all comparisons. The prevalence of AF / AT in the group studied increased with the growing post-capillary component.

2nd Department of Medicine Department of Cardiovascular Medicine General University Hospital Prague 1st Faculty of Medicine Charles University Prague Prague Czech Republic

Zobrazit více v PubMed

ALDHOON B, MELENOVSKÝ V, PEICHEL P, KAUTZNER J. New insights into mechanisms of atrial fibrillation. Physiol Res. 2010;59:1–12. doi: 10.33549/physiolres.931651. PubMed DOI

AUSMA J, WIJFFELS M, THONE F, WOUTERS L, ALLESSIE M, BORGERS M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation. 1997;96:3157–3163. doi: 10.1161/01.CIR.96.9.3157. PubMed DOI

BORLAUG BA, NISHIMURA RA, SORAJJA P, LAM CS, REDFIELD MM. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail. 2010;3:588–595. doi: 10.1161/CIRCHEARTFAILURE.109.930701. PubMed DOI PMC

CANNILLO M, GROSSO MARRA W, GILI S, D’ASCENZO F, MORELLO M, MERCANTE L, MISTRETTA E, SALERA D, ZEMA D, BISSOLINO A, FUSARO E, MARRA S, LIBERTUCCI D, GAITA F. Supraventricular arrhythmias in patients with pulmonary arterial hypertension. Am J Cardiol. 2015;116:1883–1889. doi: 10.1016/j.amjcard.2015.09.039. PubMed DOI

CHIMENTI C, RUSSO MA, CARPI A, FRUSTACI A. Histological substrate of human atrial fibrillation. Biomed Pharmacother. 2010;64:177–183. doi: 10.1016/j.biopha.2009.09.017. PubMed DOI

CIOFFI G, De SIMONE G, MUREDDU G, TARANTINI L, STEFENELLI C. Right atrial size and function in patients with pulmonary hypertension associated with disorders of respiratory system or hypoxemia. European Journal of Echocardiography. 2007;8:322–331. doi: 10.1016/j.euje.2006.06.006. PubMed DOI

D’ALTO M, ROMEO E, ARGIENTO P, MOTOJI Y, CORRERA A, Di MARCO GM, IACONO AM, BARRACANO R, D’ANDREA A, REA G, SARUBBI B, RUSSO MG, NAEIJE R. Clinical relevance of fluid challenge in patients evaluated for pulmonary hypertension. Chest. 2017;151:119–126. doi: 10.1016/j.chest.2016.08.1439. PubMed DOI

FINGROVA Z, HAVRANEK S, AMBROZ D, JANSA P, LINHART A. The left atrial substrate plays a significant role in the development of complex atrial tachycardia in patients with precapillary pulmonary hypertension. BMC Cardiovasc Disord. 2019;19:157. doi: 10.1186/s12872-019-1142-z. PubMed DOI PMC

FINGROVA Z, AMBROZ D, JANSA P, KUCHAR J, LINDNER J, KUNSTYR J, ASCHERMANN M, LINHART A, HAVRANEK S. The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension. PLoS One. 2021;16:e0245752. doi: 10.1371/journal.pone.0245752. PubMed DOI PMC

FOLINO AF, BOBBO F, SCHIRALDI C, TONA F, ROMANO S, BUJA G, BELLOTTO F. Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension. Lung. 2003;181:321–328. doi: 10.1007/s00408-003-1034-x. PubMed DOI

GALIE N, TORBICKI A, BARST R, DARTEVELLE P, HAWORTH S, HIGENBOTTAM T, OLSCHEWSKI H, PEACOCK A, PIETRA G, RUBIN LJ, SIMONNEAU G, PRIORI SG, GARCIA MA, BLANC JJ, BUDAJ A, COWIE M, DEAN V, DECKERS J, BURGOS EF, LEKAKIS J, LINDAHL B, MAZZOTTA G, McGREGOR K, MORAIS J, OTO A, SMISETH OA, BARBERA JA, GIBBS S, HOEPER M, HUMBERT M, NAEIJE R, PEPKE-ZABA J, TASK F. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J. 2004;25:2243–2278. PubMed

GALIE N, HOEPER MM, HUMBERT M, TORBICKI A, VACHIERY JL, BARBERA JA, BEGHETTI M, CORRIS P, GAINE S, GIBBS JS, GOMEZ-SANCHEZ MA, JONDEAU G, KLEPETKO W, OPITZ C, PEACOCK A, RUBIN L, ZELLWEGER M, SIMONNEAU G, GUIDELINES ESCCFP. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J. 2009;30:2493–2537. PubMed

GALIE N, HUMBERT M, VACHIERY JL, GIBBS S, LANG I, TORBICKI A, SIMONNEAU G, PEACOCK A, VONK NOORDEGRAAF A, BEGHETTI M, GHOFRANI A, GOMEZ SANCHEZ MA, HANSMANN G, KLEPETKO W, LANCELLOTTI P, MATUCCI M, McDONAGH T, PIERARD LA, TRINDADE PT, ZOMPATORI M, HOEPER M, ABOYANS V, VAZ CARNEIRO A, ACHENBACH S, AGEWALL S, ALLANORE Y, ASTEGGIANO R, PAOLO BADANO L, ALBERT BARBERA J, BOUVAIST H, BUENO H, BYRNE RA, CARERJ S, CASTRO G, EROL C, FALK V, FUNCK-BRENTANO C, GORENFLO M, GRANTON J, IUNG B, KIELY DG, KIRCHHOF P, KJELLSTROM B, LANDMESSER U, LEKAKIS J, LIONIS C, LIP GY, ORFANOS SE, PARK MH, PIEPOLI MF, PONIKOWSKI P, REVEL MP, RIGAU D, ROSENKRANZ S, VOLLER H, LUIS ZAMORANO J. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Heart J. 2016;37:67–119. doi: 10.1093/eurheartj/ehv317. PubMed DOI

MEDI C, KALMAN JM, LING LH, TEH AW, LEE G, LEE G, SPENCE SJ, KAYE DM, KISTLER PM. Atrial Electrical and Structural Remodeling Associated with Longstanding Pulmonary Hypertension and Right Ventricular Hypertrophy in Humans. J Cardiovasc Electr. 2012;23:614–620. doi: 10.1111/j.1540-8167.2011.02255.x. PubMed DOI

NGUYEN BL, FISHBEIN MC, CHEN LS, CHEN PS, MASROOR S. Histopathological substrate for chronic atrial fibrillation in humans. Heart Rhythm. 2009;6:454–460. doi: 10.1016/j.hrthm.2009.01.010. PubMed DOI PMC

OLSSON KM, NICKEL NP, TONGERS J, HOEPER MM. Atrial flutter and fibrillation in patients with pulmonary hypertension. Int J Cardiol. 2013;167:2300–2305. doi: 10.1016/j.ijcard.2012.06.024. PubMed DOI

OPITZ CF, HOEPER MM, GIBBS JS, KAEMMERER H, PEPKE-ZABA J, COGHLAN JG, SCELSI L, D’ALTO M, OLSSON KM, ULRICH S, SCHOLTZ W, SCHULZ U, GRUNIG E, VIZZA CD, STAEHLER G, BRUCH L, HUSCHER D, PITTROW D, ROSENKRANZ S. Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum. J Am Coll Cardiol. 2016;68:368–378. doi: 10.1016/j.jacc.2016.05.047. PubMed DOI

PIETRA GG, CAPRON F, STEWART S, LEONE O, HUMBERT M, ROBBINS IM, REID LM, TUDER RM. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol. 2004;43:25S–32S. doi: 10.1016/j.jacc.2004.02.033. PubMed DOI

ROSENKRANZ S, GIBBS JS, WACHTER R, De MARCO T, VONK-NOORDEGRAAF A, VACHIERY JL. Left ventricular heart failure and pulmonary hypertension. Eur Heart J. 2016;37:942–954. doi: 10.1093/eurheartj/ehv512. PubMed DOI PMC

ROTTLAENDER D, MOTLOCH LJ, SCHMIDT D, REDA S, LARBIG R, WOLNY M, DUMITRESCU D, ROSENKRANZ S, ERDMANN E, HOPPE UC. Clinical impact of atrial fibrillation in patients with pulmonary hypertension. PLoS One. 2012;7:e33902. doi: 10.1371/journal.pone.0033902. PubMed DOI PMC

SCHRIER RW, BANSAL S. Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure? Clin J Am Soc Nephrol. 2008;3:1232–1237. doi: 10.2215/CJN.01960408. PubMed DOI PMC

SIMONNEAU G, GALIE N, RUBIN LJ, LANGLEBEN D, SEEGER W, DOMENIGHETTI G, GIBBS S, LEBREC D, SPEICH R, BEGHETTI M, RICH S, FISHMAN A. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43:5S–12S. doi: 10.1016/j.jacc.2004.02.037. PubMed DOI

SMITH B, GENUARDI MV, KOCZO A, ZOU RH, THOMA FW, HANDEN A, CRAIG E, HOGAN CM, GIRARD T, ALTHOUSE AD, CHAN SY. Atrial arrhythmias are associated with increased mortality in pulmonary arterial hypertension. Pulm Circ. 2018;8:2045894018790316. doi: 10.1177/2045894018790316. PubMed DOI PMC

SPACH MS, JOSEPHSON ME. Initiating reentry: the role of nonuniform anisotropy in small circuits. J Cardiovasc Electrophysiol. 1994;5:182–209. doi: 10.1111/j.1540-8167.1994.tb01157.x. PubMed DOI

TONGERS J, SCHWERDTFEGER B, KLEIN G, KEMPF T, SCHAEFER A, KNAPP JM, NIEHAUS M, KORTE T, HOEPER MM. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J. 2007;153:127–132. doi: 10.1016/j.ahj.2006.09.008. PubMed DOI

WEN L, SUN ML, AN P, JIANG X, SUN K, ZHENG L, LIU QQ, WANG L, ZHAO QH, HE J, JING ZC. Frequency of Supraventricular Arrhythmias in Patients With Idiopathic Pulmonary Arterial Hypertension. Am J Cardiol. 2014;114:1420–1425. doi: 10.1016/j.amjcard.2014.07.079. PubMed DOI

WIJFFELS MC, KIRCHHOF CJ, DORLAND R, ALLESSIE MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954–1968. doi: 10.1161/01.CIR.92.7.1954. PubMed DOI

The impact of atrial fibrillation and atrial tachycardias on the hemodynamic status of patients with pulmonary hypertension